- Review Article
- Published:
Exploring the full spectrum of macrophage activation
Nature Reviews Immunologyvolume 8, pages958–969 (2008)Cite this article
83kAccesses
145Altmetric
ACorrigendum to this article was published on 01 June 2010
Key Points
Macrophages exhibit remarkable plasticity, which allows them to change their physiology in response to various different environmental stimuli.
The physiological characterization of each of these different macrophage populations may help to explain disease aetiologies.
The identification of biochemical markers that are specific for each of these macrophage populations may allow us to delete specific populations of macrophages, or to diagnose disease progression or resolution by the presence or absence of these populations.
Three populations of activated macrophages have been identified with unique characteristics. In addition, examples from disease states are given, in which macrophages share characteristics of more than one population. This provides a conceptual framework for a large number of different macrophage subpopulations based on this simple three-cell scaffold.
Some pathogens can exploit these changes in macrophage physiology and use macrophages for intracellular growth.
During disease progression, it is probable that macrophage populations will shift their phenotype, and this shift can contribute to disease resolution or progression.
Abstract
Macrophages display remarkable plasticity and can change their physiology in response to environmental cues. These changes can give rise to different populations of cells with distinct functions. In this Review we suggest a new grouping of macrophage populations based on three different homeostatic activities — host defence, wound healing and immune regulation. We propose that similarly to primary colours, these three basic macrophage populations can blend into various other 'shades' of activation. We characterize each population and provide examples of macrophages from specific disease states that have the characteristics of one or more of these populations.
This is a preview of subscription content,access via your institution
Access options
Subscription info for Japanese customers
We have a dedicated website for our Japanese customers. Please go tonatureasia.com to subscribe to this journal.
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Mouse and human macrophages and their roles in cardiovascular health and disease
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
References
Nathan, C. Metchnikoff's legacy in 2008.Nature Immunol.9, 695–698 (2008).
Kono, H. & Rock, K. L. How dying cells alert the immune system to danger.Nature Rev. Immunol.8, 279–289 (2008).
Erwig, L. P. & Henson, P. M. Immunological consequences of apoptotic cell phagocytosis.Am. J. Pathol.171, 2–8 (2007).
Zhang, X. & Mosser, D. M. Macrophage activation by endogenous danger signals.J. Pathol.214, 161–178 (2008).
Chen, C. J. et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells.Nature Med.13, 851–856 (2007).
Park, J. S. et al. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.J. Biol. Chem.279, 7370–7377 (2004).
Mackaness, G. B. Cellular immunity and the parasite.Adv. Exp. Med. Biol.93, 65–73 (1977).
Gordon, S. Alternative activation of macrophages.Nature Rev. Immunol.3, 23–35 (2003).
Martinez, F. O., Sica, A., Mantovani, A. & Locati, M. Macrophage activation and polarization.Front. Biosci.13, 453–461 (2008).In this paper the authors proposed that the M1 and M2 designation for macrophages should be primarily based on the ratio of IL-12 to IL-10 production.
Edwards, J. P., Zhang, X., Frauwirth, K. A. & Mosser, D. M. Biochemical and functional characterization of three activated macrophage populations.J. Leukoc. Biol.80, 1298–1307 (2006).This work shows that alternatively activated macrophages are biochemically and functionally distinct from regulatory macrophages.
Gordon, S. & Taylor, P. R. Monocyte and macrophage heterogeneity.Nature Rev. Immunol.5, 953–964 (2005).
Nahrendorf, M. et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions.J. Exp. Med.204, 3037–3047 (2007).
Sunderkotter, C. et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response.J. Immunol.172, 4410–4417 (2004).
Geissmann, F., Jung, S. & Littman, D. R. Blood monocytes consist of two principal subsets with distinct migratory properties.Immunity19, 71–82 (2003).This study shows that distinct monocyte populations exist, and have different cell-surface markers and homing capacities.
Strauss-Ayali, D., Conrad, S. M. & Mosser, D. M. Monocyte subpopulations and their differentiation patterns during infection.J. Leukoc. Biol.82, 244–252 (2007).
Passlick, B., Flieger, D. & Ziegler-Heitbrock, H. W. Identification and characterization of a novel monocyte subpopulation in human peripheral blood.Blood74, 2527–2534 (1989).
Randolph, G. J., Inaba, K., Robbiani, D. F., Steinman, R. M. & Muller, W. A. Differentiation of phagocytic monocytes into lymph node dendritic cellsin vivo.Immunity11, 753–761 (1999).
Auffray, C. et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior.Science317, 666–670 (2007).
Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W. & Rossi, F. M. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life.Nature Neurosci.10, 1538–1543 (2007).
Gordon, S. The macrophage: past, present and future.Eur. J. Immunol.37, S9–S17 (2007).
O'Shea, J. J. & Murray, P. J. Cytokine signaling modules in inflammatory responses.Immunity28, 477–487 (2008).
Dale, D. C., Boxer, L. & Liles, W. C. The phagocytes: neutrophils and monocytes.Blood112, 935–945 (2008).
Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway.Science301, 640–643 (2003).This work shows that mice lacking the TLR adaptor molecule TRIF are defective in TLR3- and TLR4-mediated IFNγ production.
Langrish, C. L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.J. Exp. Med.201, 233–240 (2005).
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supportsde novo differentiation of IL-17-producing T cells.Immunity24, 179–189 (2006).
Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.Nature441, 235–238 (2006).
Kolls, J. K. & Linden, A. Interleukin-17 family members and inflammation.Immunity21, 467–476 (2004).
Fadok, V. A. et al. Macrophages that have ingested apoptotic cellsin vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF.J. Clin. Invest.101, 890–898 (1998).This work shows that the phagocytosis of apoptotic cells by macrophages is associated with the production of TGFβ, which inhibits the production of pro-inflammatory cytokines.
Filipe-Santos, O. et al. Inborn errors of IL-12/23- and IFN-γ-mediated immunity: molecular, cellular, and clinical features.Semin. Immunol.18, 347–361 (2006).
Nandan, D. & Reiner, N. E. Attenuation of γ interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected withLeishmania donovani: selective inhibition of signaling through Janus kinases and Stat1.Infect. Immun.63, 4495–4500 (1995).
Pai, R. K., Convery, M., Hamilton, T. A., Boom, W. H. & Harding, C. V. Inhibition of IFN-γ-induced class II transactivator expression by a 19-kDa lipoprotein fromMycobacterium tuberculosis: a potential mechanism for immune evasion.J. Immunol.171, 175–184 (2003).
Szekanecz, Z. & Koch, A. E. Macrophages and their products in rheumatoid arthritis.Curr. Opin. Rheumatol.19, 289–295 (2007).
Loke, P. et al. Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection.J. Immunol.179, 3926–3936 (2007).This study shows that the production of IL-4 and IL-13 is a rapid innate immune response to tissue injury.
Brandt, E., Woerly, G., Younes, A. B., Loiseau, S. & Capron, M. IL-4 production by human polymorphonuclear neutrophils.J. Leukoc. Biol.68, 125–130 (2000).
Reese, T. A. et al. Chitin induces accumulation in tissue of innate immune cells associated with allergy.Nature447, 92–96 (2007).This work demonstrates that chitin induces the production of IL-4 by eosinophils and basophils.
Kreider, T., Anthony, R. M., Urban, J. F. Jr & Gause, W. C. Alternatively activated macrophages in helminth infections.Curr. Opin. Immunol.19, 448–453 (2007).
Stein, M., Keshav, S., Harris, N. & Gordon, S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation.J. Exp. Med.176, 287–292 (1992).This is the initial observation that IL-4 upregulates the expression of macrophage mannose receptor, thereby giving rise to the term alternative activation.
Raes, G., Beschin, A., Ghassabeh, G. H. & De, B. P. Alternatively activated macrophages in protozoan infections.Curr. Opin. Immunol.19, 454–459 (2007).
Wilson, M. S. et al. Immunopathology of schistosomiasis.Immunol. Cell Biol.85, 148–154 (2007).
Cordeiro-da-Silva, A. et al. Immunological alterations induced by polyamine derivatives on murine splenocytes and human mononuclear cells.Int. Immunopharmacol.4, 547–556 (2004).
Anthony, R. M. et al. Memory TH2 cells induce alternatively activated macrophages to mediate protection against nematode parasites.Nature Med.12, 955–960 (2006).
Zhao, A. et al. Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages.Gastroenterology135, 217–225 (2008).
Raes, G. et al. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages.J. Leukoc. Biol.71, 597–602 (2002).
Kzhyshkowska, J. et al. Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway.Blood107, 3221–3228 (2006).
Zhu, Z. et al. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation.Science304, 1678–1682 (2004).
Bleau, G., Massicotte, F., Merlen, Y. & Boisvert, C. Mammalian chitinase-like proteins.EXS87, 211–221 (1999).
Fusetti, F. et al. Structure of human chitotriosidase. Implications for specific inhibitor design and function of mammalian chitinase-like lectins.J. Biol. Chem.277, 25537–25544 (2002).
Hesse, M. et al. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokinesin vivo: granulomatous pathology is shaped by the pattern ofL-arginine metabolism.J. Immunol.167, 6533–6544 (2001).This study shows that arginase-1 production by alternatively activated macrophages depends on TH2-type cytokines and inversely correlates with nitric oxide production.
Munitz, A., Brandt, E. B., Mingler, M., Finkelman, F. D. & Rothenberg, M. E. Distinct roles for IL-13 and IL-4 via IL-13 receptor α1 and the type II IL-4 receptor in asthma pathogenesis.Proc. Natl Acad. Sci. USA105, 7240–7245 (2008).
Harris, J. et al. T helper 2 cytokines inhibit autophagic control of intracellularMycobacterium tuberculosis.Immunity27, 505–517 (2007).
Kropf, P. et al. Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasisin vivo.FASEB J.19, 1000–1002 (2005).
Muller, U. et al. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice withCryptococcus neoformans.J. Immunol.179, 5367–5377 (2007).
Shirey, K. A., Cole, L. E., Keegan, A. D. & Vogel, S. N.Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism.J. Immunol.181, 4159–4167 (2008).
Tumitan, A. R., Monnazzi, L. G., Ghiraldi, F. R., Cilli, E. M. & hado de Medeiros, B. M. Pattern of macrophage activation inYersinia-resistant andYersinia-susceptible strains of mice.Microbiol. Immunol.51, 1021–1028 (2007).
Sternberg, E. M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens.Nature Rev. Immunol.6, 318–328 (2006).
Elenkov, I. J. Glucocorticoids and the Th1/Th2 balance.Ann. N. Y. Acad. Sci.1024, 138–146 (2004).
Liu, Y. et al. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes.J. Immunol.162, 3639–3646 (1999).
Franchimont, D. Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies.Ann. NY Acad. Sci.1024, 124–137 (2004).
Mosser, D. M. The many faces of macrophage activation.J. Leukoc. Biol.73, 209–212 (2003).
Lucas, M., Zhang, X., Prasanna, V. & Mosser, D. M. ERK activation following macrophage FcγR ligation leads to chromatin modifications at the IL-10 locus.J. Immunol.175, 469–477 (2005).This paper shows that activation of ERK is required for the hypersecretion of IL-10 by regulatory macrophages.
Gerber, J. S. & Mosser, D. M. Reversing lipopolysaccharide toxicity by ligating the macrophage Fcγ receptors.J. Immunol.166, 6861–6868 (2001).
Strassmann, G., Patil-Koota, V., Finkelman, F., Fong, M. & Kambayashi, T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.J. Exp. Med.180, 2365–2370 (1994).
Hasko, G., Pacher, P., Deitch, E. A. & Vizi, E. S. Shaping of monocyte and macrophage function by adenosine receptors.Pharmacol. Ther.113, 264–275 (2007).
Hasko, G., Szabo, C., Nemeth, Z. H. & Deitch, E. A. Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a β-adrenoceptor-mediated mechanism.J. Neuroimmunol.122, 34–39 (2002).
Sirois, J., Menard, G., Moses, A. S. & Bissonnette, E. Y. Importance of histamine in the cytokine network in the lung through H2 and H3 receptors: stimulation of IL-10 production.J. Immunol.164, 2964–2970 (2000).
Weigert, A. et al. Tumor cell apoptosis polarizes macrophages role of sphingosine-1-phosphate.Mol. Biol. Cell18, 3810–3819 (2007).
Lam, C. W., Perretti, M. & Getting, S. J. Melanocortin receptor signaling in RAW264.7 macrophage cell line.Peptides27, 404–412 (2006).
Delgado, M., Munoz-Elias, E. J., Gomariz, R. P. & Ganea, D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages:in vitro andin vivo studies.J. Immunol.162, 1707–1716 (1999).
Huang, H., Park, P. H., McMullen, M. R. & Nagy, L. E. Mechanisms for the anti-inflammatory effects of adiponectin in macrophages.J. Gastroenterol. Hepatol.1, S50–S53 (2008).
Ando, M., Tu, W., Nishijima, K. & Iijima, S. Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs.Biochem. Biophys. Res. Commun.369, 878–883 (2008).
Biswas, S. K. et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation).Blood107, 2112–2122 (2006).In this study, tumour-associated macrophages are profiled by microarray analysis.
Miles, S. A., Conrad, S. M., Alves, R. G., Jeronimo, S. M. & Mosser, D. M. A role for IgG immune complexes during infection with the intracellular pathogenLeishmania.J. Exp. Med.201, 747–754 (2005).
Baetselier, P. D. et al. Alternative versus classical macrophage activation during experimental African trypanosomosis.Int. J. Parasitol.31, 575–587 (2001).
Kim, C. et al. Antiinflammatory cAMP signaling and cell migration genes co-opted by the anthrax bacillus.Proc. Natl Acad. Sci. USA105, 6150–6155 (2008).
Agrawal, A. & Pulendran, B. Anthrax lethal toxin: a weapon of multisystem destruction.Cell Mol. Life Sci.61, 2859–2865 (2004).
Benoit, M., Barbarat, B., Bernard, A., Olive, D. & Mege, J. L.Coxiella burnetii, the agent of Q fever, stimulates an atypical M2 activation program in human macrophages.Eur. J. Immunol.38, 1065–1070 (2008).
Mahalingam, S. & Lidbury, B. A. Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-κB) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus.Proc. Natl Acad. Sci. USA99, 13819–13824 (2002).
Stout, R. D. et al. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences.J. Immunol.175, 342–349 (2005).
Klimp, A. H., de Vries, E. G., Scherphof, G. L. & Daemen, T. A potential role of macrophage activation in the treatment of cancer.Crit. Rev. Oncol. Hematol.44, 143–161 (2002).
Teng, M. W., Swann, J. B., Koebel, C. M., Schreiber, R. D. & Smyth, M. J. Immune-mediated dormancy: an equilibrium with cancer.J. Leukoc. Biol.84, 988–993 (2008).
Lin, E. Y. & Pollard, J. W. Tumor-associated macrophages press the angiogenic switch in breast cancer.Cancer Res.67, 5064–5066 (2007).This work correlates macrophage recruitment into tumours with an angiogenic switch and a poor prognosis.
Swann, J. B. et al. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis.Proc. Natl Acad. Sci. USA105, 652–656 (2008).
Romieu-Mourez, R. et al. Distinct roles for IFN regulatory factor (IRF)-3 and IRF-7 in the activation of antitumor properties of human macrophages.Cancer Res.66, 10576–10585 (2006).
Pollard, J. W. Macrophages define the invasive microenvironment in breast cancer.J. Leukoc. Biol.84, 623–630 (2008).
Liu, C. H. et al. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice.J. Biol. Chem.276, 18563–18569 (2001).
Knowles, H. J. & Harris, A. L. Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis.Breast Cancer Res.3, 318–322 (2001).
Kuang, D. M. et al. Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes.Blood110, 587–595 (2007).
de Visser, K. E., Korets, L. V. & Coussens, L. M.De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent.Cancer Cell7, 411–423 (2005).
Hagemann, T. et al. “Re-educating” tumor-associated macrophages by targeting NF-κB.J. Exp. Med.205, 1261–1268 (2008).
Lin, E. Y. et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer.Cancer Res.66, 11238–11246 (2006).
Lumeng, C. N., Bodzin, J. L. & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization.J. Clin. Invest.117, 175–184 (2007).
Straus, D. S. & Glass, C. K. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms.Trends Immunol.28, 551–558 (2007).
Heilbronn, L. K. & Campbell, L. V. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity.Curr. Pharm. Des.14, 1225–1230 (2008).
Zeyda, M. & Stulnig, T. M. Adipose tissue macrophages.Immunol. Lett.112, 61–67 (2007).
Cinti, S. et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.J. Lipid Res.46, 2347–2355 (2005).
Bastard, J. P. et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance.Eur. Cytokine Netw.17, 4–12 (2006).
Hansson, G. K., Robertson, A. K. & Soderberg-Naucler, C. Inflammation and atherosclerosis.Annu. Rev. Pathol.1, 297–329 (2006).
Fernandez, A. Z. Peroxisome proliferator-activated receptors in the modulation of the immune/inflammatory response in atherosclerosis.PPAR Res.2008, 285842 (2008).
Martin-Fuentes, P. et al. Individual variation of scavenger receptor expression in human macrophages with oxidized low-density lipoprotein is associated with a differential inflammatory response.J. Immunol.179, 3242–3248 (2007).
Haque, S., Mirjafari, H. & Bruce, I. N. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.Curr. Opin. Lipidol.19, 338–343 (2008).
Roark, C. L., Simonian, P. L., Fontenot, A. P., Born, W. K. & O'Brien, R. L. γδ T cells: an important source of IL-17.Curr. Opin. Immunol.20, 353–357 (2008).
Mangan, P. R. et al. Transforming growth factor-β induces development of the TH17 lineage.Nature441, 231–234 (2006).
costa-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A. & Sallusto, F. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells.Nature Immunol.8, 942–949 (2007).
Denning, T. L., Wang, Y. C., Patel, S. R., Williams, I. R. & Pulendran, B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses.Nature Immunol.8, 1086–1094 (2007).
Jovanovic, D. V. et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-α, by human macrophages.J. Immunol.160, 3513–3521 (1998).
Sato, K. et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction.J. Exp. Med.203, 2673–2682 (2006).
Trinchieri, G. Interleukin-12 and the regulation of innate resistance and adaptive immunity.Nature Rev. Immunol.3, 133–146 (2003).
MacMicking, J., Xie, Q. W. & Nathan, C. Nitric oxide and macrophage function.Annu. Rev. Immunol.15, 323–350 (1997).
Martinez, F. O., Gordon, S., Locati, M. & Mantovani, A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression.J. Immunol.177, 7303–7311 (2006).
Kodelja, V. et al. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 α with a Th2-associated expression pattern.J. Immunol.160, 1411–1418 (1998).
Raes, G. et al. FIZZ1 and Ym as tools to discriminate between differentially activated macrophages.Dev. Immunol.9, 151–159 (2002).
Wirnsberger, G., Hebenstreit, D., Posselt, G., Horejs-Hoeck, J. & Duschl, A. IL-4 induces expression of TARC/CCL17 via two STAT6 binding sites.Eur. J. Immunol.36, 1882–1891 (2006).
Ruckerl, D., Hessmann, M., Yoshimoto, T., Ehlers, S. & Holscher, C. Alternatively activated macrophages express the IL-27 receptor α chain WSX-1.Immunobiology211, 427–436 (2006).
Wynes, M. W. & Riches, D. W. Induction of macrophage insulin-like growth factor-I expression by the Th2 cytokines IL-4 and IL-13.J. Immunol.171, 3550–3559 (2003).
Mantovani, A., Sozzani, S., Locati, M., Allavena, P. & Sica, A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.Trends Immunol.23, 549–555 (2002).
Goerdt, S. & Orfanos, C. E. Other functions, other genes: alternative activation of antigen presenting cells.Immunity10, 137–142 (1999).
Torocsik, D., Bardos, H., Nagy, L. & Adany, R. Identification of factor XIII-A as a marker of alternative macrophage activation.Cell. Mol. Life Sci.62, 2132–2139 (2005).
Sironi, M. et al. Differential regulation of chemokine production by Fcγ receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2).J. Leukoc. Biol.80, 342–349 (2006).
Stumhofer, J. S. & Hunter, C. A. Advances in understanding the anti-inflammatory properties of IL-27.Immunol. Lett.117, 123–130 (2008).
Acknowledgements
This work is supported in part by National Institutes of Health grants AI49388 and AI55576.
Author information
Authors and Affiliations
Department of Cell Biology and Molecular Genetics and the Maryland Pathogen Research Institute, University of Maryland, College Park, 20742, Maryland, USA
David M. Mosser & Justin P. Edwards
- David M. Mosser
You can also search for this author inPubMed Google Scholar
- Justin P. Edwards
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toDavid M. Mosser.
Related links
Glossary
- Apoptosis
A common form of cell death (also known as programmed cell death) that can be caused by many physiological and developmental stimuli. Apoptosis involves cell shrinkage, chromatin condensation in the periphery of the nucleus, cell-membrane blebbing and DNA fragmentation into multiples of∼180 base pairs. Eventually, the cell breaks up into many membrane-bound apoptotic bodies, which are phagocytosed by neighbouring cells.
- Necrosis
A form of cell death that frequently results from toxic injury, hypoxia or stress. Necrosis involves the loss of cell integrity and the release of cell contents into the interstitium. This form of cell death usually occurs together with inflammation. Depending on the context, the self antigens that are released by necrotic cells could become immunogenic.
- Extracellular matrix
Secreted products of many cell types that form an organized scaffold for cell support.
- Classically activated macrophage
A macrophage that is activated through Toll-like receptors and interferon-γ. These cells exhibit enhanced killing of intracellular microorganisms, increased secretion of cytokines and mediators, and higher expression of co-stimulatory molecules.
- Alternatively activated macrophage
A macrophage that is activated by interleukin-4 (IL-4) or IL-13 and expresses arginase-1, mannose receptor (CD206) and IL-4 receptor-α. Pathogen-associated molecular patterns that are expressed by helminths may also drive the alternative activation of macrophages.
- Superoxide anions
Anions that are produced by NADPH oxidase in phagocytes and can dismutate to hydrogen peroxide, which can be converted into ferryl or hydroxyl radicals by the Fenton reaction.
- Osteoclastogenesis
A process whereby haematopoietic stem cells differentiate into multinucleated osteoclasts with bone-resorbing activity.
- Chitinase
An enzyme that breaks down the glycosidic bonds in chitin.
- Autophagy
An evolutionarily conserved process during which acidic double-membrane vacuoles sequester intracellular contents (such as damaged organelles and macromolecules) and target them for degradation through fusion to secondary lysosomes.
- Hypothalamic–pituitary–adrenal axis
A major part of the neuroendocrine system, which controls reactions to stress and regulates digestion, energy use, sexuality and the immune system (generally through an immunosuppressive action).
- Glucocorticoids
A group of compounds that belongs to the corticosteroid family. These compounds can be naturally produced (hormones) or can be synthetic. They affect metabolism and have anti-inflammatory and immunosuppressive effects. Some synthetic glucocorticoids (for example, dexamethasone) are used as chemotherapeutic drugs.
- Immune complexes
Antigen–antibody complexes that bind to and crosslink Fcγ receptors.
- Prostaglandins
Lipid mediators that are derived from arachidonic acid through the cyclooxygenase pathway. Bergstrom, Samuelsson and Vane won the Nobel prize in Medicine in 1982 for showing that aspirin-like compounds could inhibit prostaglandin synthesis.
- G-protein-coupled receptor
A receptor that is composed of seven membrane-spanning helical segments, which are connected by extracellular and intracellular loops. These receptors associate with G proteins, which are a family of trimeric intracellular-signalling proteins that have specific β- and γ-chains, and one of several α-achains.
- Tumour-associated macrophage
A cell that differentiates from circulating blood monocytes that have infiltrated tumours. Tumour-associated macrophages constitute an important component of the tumour microenvironment and can have positive or negative effects on tumorigenesis (that is, tumour promotion or immunosurveillance, respectively).
- Antibody-dependent enhancement
A phenomenon that was originally described in Dengue virus infection in which the presence of antibody enhances viral infection and increases disease severity.
- Neoplasia
New growths or tumours, which can be either benign or malignant. Derived from the Greek for new formations.
- Angiogenesis
The development of new blood vessels from existing ones. Angiogenesis is frequently associated with tumour development and metastasis.
- Adipose tissue
Loose connective tissue consisting primarily of adipocytes, the major function of which is to store energy in the form of fat.
- Insulin resistance
Failure of cells to appropriately respond to insulin-mediated induction of glucose uptake, resulting in increased blood sugar levels and possibly type 2 diabetes.
- Metabolic syndrome
A combination of disorders, including hypertension, obesity, high blood glucose levels and dyslipidaemia, that can result in cardiovascular disease.
Rights and permissions
About this article
Cite this article
Mosser, D., Edwards, J. Exploring the full spectrum of macrophage activation.Nat Rev Immunol8, 958–969 (2008). https://doi.org/10.1038/nri2448
Issue Date:
